CClinicalTrials.gg
CompletedNCT00845234Updated Feb 26, 2013

Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient Education

An interventional study of Intervention in Arrhythmia, sponsored by East Carolina University. Completed at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-02-26.

Sponsored by East Carolina University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

An implantable cardioverter defibrillator (ICD) administers a shock to terminate potentially life-threatening cardiac arrhythmias. The device saves lives, but presents psychological challenges for patients. At present, there is a paucity of brief interventions for ICD patients designed for administration in a clinic setting that considers issues of cost, time, and available resources. The present study examined the impact of a brief cognitive behavioral (CBT) educational intervention on primary endpoints of patient acceptance and quality of life and secondary endpoints of depression and anxiety. It was hypothesized that the intervention would result in significant improvements primary and secondary endpoints for participants in the intervention group.

02

Conditions studied

  • Arrhythmia

Browse trials for

Keywords

  • behavioral intervention
  • implantable cardioverter defibrillator
  • psychosocial education
  • anxiety
  • depression
03

In context

Arrhythmias, Cardiac

885 studies on the registry are indexed under Arrhythmias, Cardiac; 235 are open to participants now.

This study's enrollment of 62 is below the median of 99 across 429 interventional studies indexed under Arrhythmias, Cardiac.

Browse Arrhythmias, Cardiac studies →

Lead sponsor

East Carolina University is the lead sponsor of 83 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 18+ years old
  • literate
  • newly implanted with an implantable cardioverter defibrillator (ICD)

Exclusion criteria

Exclusion Criteria:

  • documented neurological sequelae associated with CVA or dementia
  • documented cognitive impairment
  • reported illiteracy
  • previously implanted ICD
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
62 participants (actual)

Study arms

  • No intervention
    Standard of Care Group

    Received the current standard of care as operationally defined by the investigators- Q\&A session + Video

  • Experimental
    Intervention Group

    Intervention group- Patients will receive the brief educational CBT intervention + video and Q\&A session

    Behavioral: Intervention

Interventions

  • BehavioralIntervention

    Intervention consisted of a brief, educational CBT intervention and included the following domain areas: ICD knowledge and post-discharge care, understanding shock, stress management, family and relationships, device recall, and survivorship. The intervention was provided at baseline (0 weeks). Intervention was led by investigator and lasted 15 minutes in duration.

06

What researchers measure

Primary outcomes

  1. Score on measure assessing construct of quality of life

    Quality of life will be obtained via participants scores from the Medical Outcomes Survey Short Form-12 (SF-12) measure of quality of life.

    Time frame: Up to 8 months after enrollment

Secondary outcomes

  1. Score on measure assessing depression

    Depression will be assessed via participant's self-reported scores on the depression subscale of the Hospital Anxiety and Depression Scale (HADS).

    Time frame: Up to 8 months after enrollment

  2. score on measure assessing construct of patient acceptance of device

    The Florida Patient Acceptance Scale measures patient's self-reported acceptance of the implantable cardioverter defibrillator.

    Time frame: up to 8 months after enrollment

  3. score on measure assessing anxiety

    The Hospital Anxiety and Depression Scale is comprised of two subscales- anxiety and depression. It is a self-report measure that generates a score on the patient's current level of anxiety.

    Time frame: Up to 8 months after enrollment

07

Study locations

3 sites
  • Aurora Denver Cardiology Associates
    Aurora, Colorado 80012, United States
  • Aurora Denver Cardiology Associates
    Lone Tree, Colorado 80124, United States
  • East Carolina Heart Institute
    Greenville, North Carolina 27834, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00845234
Lead sponsor
East Carolina University
Collaborators
Aurora Denver Cardiology Associates, Medtronic
Responsible party
Samuel F. Sears (Professor, East Carolina University) — Principal investigator
First posted
Feb 18, 2009
Start date
Jul 2008
Primary completion
Jan 2011
Completion
Jan 2011
Last update
Feb 26, 2013

Study contacts

Samuel F Sears, Ph.D.
principal investigator · East Carolina University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion